Comparison of itraconacole, voriconazole and posaconazole as oral antifungal prophylaxis in paediatric patients following allogeneic stem cell transplantation

被引：0
|
作者：
Doering, M. [1 ]
Blume, O. [1 ]
Hartmann, U. [1 ]
Kimmig, A. [1 ]
Schwarze, C. -P. [1 ]
Handgretinger, R. [1 ]
Mueller, I. [2 ]
机构：
[1] Univ Childrens Hosp, Tubingen, Germany
[2] Univ Med Ctr, Hamburg, Germany
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S223 / S223
页数：1
相关论文
共 50 条
  • [31] Voriconazole as antifungal prophylaxis in allogeneic hematopoietic stem cell transplantation: ten years of experience in a single institution
    Chic Acevedo, C.
    Llamas Poyato, M. J.
    Garcia Torres, E.
    Mari, P.
    Diez, G.
    Serrano, J.
    Molina, J. R.
    Martin, C.
    Martinez, F.
    Herrera, C.
    Rojas, R.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S129 - S129
  • [32] VORICONAZOLE AS PRIMARY ANTIFUNGAL PROPHYLAXIS IN RECIPIENTS OF ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION FROM ALTERNATIVE DONORS
    Cozzi, J.
    Basso, A.
    Lein, J.
    Saslavsky, J.
    Saslavsky, M.
    Pilli, V
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S283 - S284
  • [33] Oral voriconazole for prophylaxis of fungal infections during allogeneic hematopoietic stem cell transplantation in patients at risk.
    Schleuning, M
    Judith, D
    Thoedtmann, R
    Baurmann, H
    Schwerdtfeger, R
    BLOOD, 2003, 102 (11) : 442B - 442B
  • [34] Breakthrough zygomycosis on posaconazole prophylaxis after allogeneic stem cell transplantation
    Mousset, S.
    Bug, G.
    Heinz, W. J.
    Tintelnot, K.
    Rickerts, V.
    TRANSPLANT INFECTIOUS DISEASE, 2010, 12 (03) : 261 - 264
  • [35] Pharmacokinetic Analysis during Antifungal Prophylaxis with Posaconazole Suspension in Pediatric and Adolescent Patients after Allogeneic Hematopoietic Stem Cell Transplantation
    Doering, Michaela
    Stanchi, Karin Melanie Cabanillas
    Queudeville, Manon
    Feucht, Judith
    Schlegel, Patrick
    Feuchtinger, Tobias
    Lang, Peter
    Handgretinger, Rupert
    Heinz, Werner J.
    BLOOD, 2015, 126 (23)
  • [36] Primary antifungal prophylaxis with posaconazole vs fluconazole in early neutropenic phase after allogeneic stem cell transplantation
    Mele, A.
    Greco, G.
    De Risi, C.
    Sibilla, S.
    Rossini, B.
    Carlino, D.
    Citiso, S.
    Prete, E.
    Morciano, M. R.
    Peluso, A.
    Pavone, V.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S582 - S583
  • [37] DECREASE OF INVASIVE FUNGAL DISEASE IN OUR CENTER WITH THE USE OF VORICONAZOLE AS ANTIFUNGAL PROPHYLAXIS IN PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION
    Llamas Poyato, M. J.
    Chic Acevedo, C.
    Garcia, E.
    Buenasmananas, D.
    Serrano, J.
    Molina, J. R.
    Martin, C.
    Rojas, R.
    HAEMATOLOGICA, 2014, 99 : 168 - 168
  • [38] Secondary antifungal prophylaxis in paediatric allogeneic haematopoietic stem cell recipients
    Allinson, Katherine
    Kolve, Hedwig
    Gumbinger, Hans G.
    Vormoor, H. Josef
    Ehlert, Karoline
    Groll, Andreas H.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (03) : 734 - 742
  • [39] Secondary Antifungal Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation
    Pepeler, M. S.
    Yildiz, S.
    Yegin, Z. A.
    Ozkurt, Z. N.
    Tuncan, O. Guzel
    Erbas, G.
    Kokturk, N.
    Yildirim, Z.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S398 - S398
  • [40] Reduced-Dose Posaconazole as Antifungal Prophylaxis in Allogeneic Stem Cell Transplant Recipients
    Elayan, Mohammed M.
    Sepp, Caitlin
    Siler, Darby
    Bachier, Carlos R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S391 - S391
12345